首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到18条相似文献,搜索用时 171 毫秒
1.
目的 观察单侧输尿管梗阻(UUO)模型大鼠肾组织α-平滑肌肌动蛋白(α-SMA)、过氧化物酶体增殖物激活受体(PPART)表达变化及其与肾小管间质纤维化间的关系。方法 36只SD大鼠随机分为假手术组(n=6)和模型组(n=30)。模型组行UU0术,并随机分为3、7、14、21和28d组。相应时间点活杀动物,取肾脏,用常规苏木素-伊红(HE)、Masson、高碘酸-乌洛托品银(PASM)染色,观察肾小管病变程度;用免疫组化法测定UU0大鼠梗阻肾不同时间点α-SMA和PPARγ表达变化及与肾脏病理变化间的关系。结果 病理学结果显示,UUO3和7d时肾小管上皮细胞肿胀,炎症细胞浸润,纤维组织增生尚不明显;14d和21d时肾皮质大量炎症细胞浸润及纤维组织增生;28d时表现为肾小管严重破坏,纤维组织弥漫增生。免疫组化结果显示,PPARγ在假手术组肾组织中几乎无表达;UUO模型大鼠随着病变进展,肾组织PPARγ表达增加,主要分布在肾小管上皮细胞、浸润的单核细胞,3d时表达量开始增加,14d达高峰,此后表达略有减少,但仍显著高于假手术组及3d和7d组。假手术组α-SMA仅表达于血管平滑肌肌层,3d时肾闻质出现表达,14~21d表达显著增加,阳性信号弥漫分布,高峰持续至28d实验结束。结论 PPARγ在UUO大鼠显著升高,其表达与α-SMA的表达量及肾小管间质病变程度早期一致,14d达峰值后表达不再随病变加重而进一步升高。UUO病变早期PPARγ反应性升高可能在肾脏局部炎症和纤维化病程中发挥了重要作用。  相似文献   

2.
【目的】探讨PAX2基因在梗阻性肾病大鼠肾小管上皮细胞的重新表达对肾间质纤维化的意义。【方法】80只大鼠随机分为:假手术组(sham组)和模型组(UUO组)各40只。于术后3d、5d、7d、14d(每组10只)处死取肾组织。光镜观察肾脏病理形态改变,免疫组化、Westernblot及realtimePCR检测肾组织PAX2蛋白和mRNA的表达。【结果】①HE和Masson染色观察到UUO组肾间质呈现明显的纤维化。②免疫组化发现sham组肾小管上皮细胞无PAX2表达;UUO组肾小管上皮细胞表达较多;③Westernblot显示PAX2蛋白水平在UU0组术后3d相比sham组明显的增加(P〈0.05),随着梗阻时间延长PAX2蛋白表达更加明显;④realtimePCR显示,PAX2mRNA与PAX2蛋白的,矗达趋势相同。⑤相关分析:PAX2蛋白水平与肾小管损伤程度呈正相关(r=0.991,P〈0.05),与肾间质纤维化程度呈正相关(r=0.985,P〈0.05)。【结论】胚胎发育基因PAX2在梗阻性肾病大鼠肾小管存在重新表达;并参与了梗阻性肾病肾小管损伤和肾间质纤维化的过程。  相似文献   

3.
目的:研究缬沙坦对糖尿病大鼠肾小管上皮细胞转化生长因子β1与结缔组织生长因子表达的影响。方法:将60只W istar大鼠随机分为对照组(n=20)和糖尿病模型组(n=40),糖尿病模型组给予一次腹腔注射链脲佐菌素制造糖尿病模型,模型成功后随机分为糖尿病组(n=20)和缬沙坦组(n=20);缬沙坦组每日给予缬沙坦30 m g/kg的剂量灌胃;第8周测定各组大鼠尿蛋白,处死大鼠取肾组织石蜡包埋切片,免疫组织化学法观察肾小管上皮细胞转化生长因子β1与结缔组织生长因子表达并进行半定量分析。结果:糖尿病大鼠尿蛋白排泄显著高于对照组(P<0.01),肾间质损害明显,糖尿病组大鼠肾小管上皮细胞转化生长因子β1与结缔组织生长因子阳性表达相对面积分别为0.2209±0.0405和0.1835±0.0611,与对照组比较均显著上调(P<0.01);缬沙坦组大鼠尿蛋白排泄较糖尿病组显著下降,其肾小管上皮细胞转化生长因子β1与结缔组织生长因子阳性表达相对面积分别为0.1435±0.0322和0.1183±0.0376,较糖尿病组显著下调(P<0.01)。结论:缬沙坦能显著下调糖尿病大鼠肾小管上细胞转化生长因子β1与结缔组织生长因子表达。  相似文献   

4.
目的:观察联合应用福辛普利和缬沙坦对梗阻性肾病模型(UUO)大鼠肾小管间质MMP-7表达的影响,初步探讨其在肾间质纤维化中的作用机制。方法:72只Wistar雌性幼年大鼠单侧输尿管结扎制成UUO模型,并随机分为假手术对照组(A组)、UUO模型组(B组)和福辛普利及缬沙坦联合治疗组(C组),于模型成功后第1,2,3,4周末为实验时间点,检测各组大鼠24h尿蛋白、血尿素氮(BUN)、血肌酐(SCr)。用免疫组化法研究MMP-7在肾组织的分布、表达及变化。结果:光镜下MMP-7在对照组肾小管上皮细胞胞浆呈阴性表达,术后1周UUO组MMP-7在肾小管上皮细胞胞浆区及肾间质细胞表达,在血管内皮细胞有微量表达,2周后表达增强,4周表达最强。治疗组各周MMP-7表达较UUO组下调。结论:联合应用福辛普利和缬沙坦可通过下调MMP-7在肾组织的表达而改善肾功能,延缓肾间质纤维化的进展。  相似文献   

5.
目的研究促肝细胞生长素(pHGF)对肾间质纤维化大鼠肾组织中HGF、TGF-β1的表达的影响及其改善肾小管间质纤维化可能的机制,为临床防治肾间质纤维化提供实验性理论依据。方法采用单侧输尿管结扎术(unilateral ureteral obstruction UUO)建立肾小管间质纤维化大鼠模型。将54只大鼠随机分为三组:假手术组,UUO组,pHGF干预组。术后3、7、14天分3批处死各组大鼠,分别经免疫组化方法观察各组大鼠肾组织HGF、TGF-β1的表达情况,HE及Masson染色评定各组肾小管间质损害程度。结果UUO组TGF-β1的表达及肾小管间质损伤程度明显高于假手术组(P〈0.05);而pHGF干预组明显低于UUO组(P〈0.05);UUO组HGF于第3天表达最高,第7天稍有回落,第14天表达最弱;pHGF干预组术后第3天、第7天、第14天HGF的表达均显著高于同时期UUO组(P〈0.05),肾小管间质病变程度明显减轻,肾间质相对面积显著减小(P〈0.05)。结论pHGF能够减轻单侧输尿管结扎大鼠肾间质纤维化的程度,这种作用可能通过有效抑制肾间质中TGF-β1的过度表达、促进肾间质HGF的表达而实现。  相似文献   

6.
LV Yun-bo  曾秋棠 《实用医学杂志》2008,24(16):2764-2766
目的:观察依达拉奉对心肌缺血/再灌注后心肌细胞凋亡的影响。方法:选择30只健康SD大鼠,采用结扎冠状动脉左前降支后再通的方法复制心肌缺血再灌注的动物模型,随机分为假手术组(n=10)、缺血/再灌注(I/R)组(n=10)和药物(依达拉秦)组(n=10)。检测各组3h后心肌组织的超氧化物歧化酶(SOD)和丙二醛(MDA)的含量。并用免疫组化法测定局部凋亡相关因子Bcl-2、Fas的表达,比较各组间差异。结果:与假手术组比较,I/R组中反映氧化损伤程度的MDA明显升高(P〈0.01),抗氧化酶SOD则明显减少(P〈0.01),Fas含量升高(P〈0、01),Bcl-2含量明显减少(P〈0、01);药物组较I/R组MDA含量明显减少(P〈0.01),SOD活性显著增加(P〈0.01),Fas含量明显降低(P〈0,05),Bcl-2含量明显增加(P〈0.01)。结论:依达拉奉具有抗心肌缺血再灌注损伤作用,其机制可能是通过调节Bcl-2和Fas介导的细胞凋亡而实现  相似文献   

7.
目的 探究肾茶总黄酮调节实验大鼠缺血再灌注损伤后肾小管上皮细胞凋亡的作用和机制。方法 60只雄性实验SD大鼠,信封法随机编码分为4组(n=15只),对照组、模型组、肾茶总黄酮小剂量治疗组、肾茶总黄酮大剂量治疗组。模型组、肾茶总黄酮小剂量治疗组和肾茶总黄酮大剂量治疗组均采用手术摘除实验大鼠右侧肾脏,持续阻断左肾动脉1h后恢复灌注的方法建立急性肾缺血再灌注损伤模型,通过酶偶联法测定模型大鼠血肌酐(Cr)、尿素氮(BUN)的变化并比较,确认模型建立成功;对照组、模型组以0.9%氯化钠溶液灌胃,治疗组以肾茶总黄酮溶液灌胃(高剂量400mg/Kg、小剂量100mg/Kg),治疗4天;TUNEL法检测大鼠肾小管上皮细胞凋亡指数(AI);肾组织匀浆后,黄嘌呤氧化酶法测定SOD,化学比色法测定NOS和硫代巴比妥酸法测定MDA含量。结果 模型组Cr(94.76±13.83)、BUN(25.34±2.46),与对照组Cr(55.41±9.83)、BUN(13.84±1.53)比较显著升高(P<0.05),显示造模成功;经肾茶总黄酮大剂量治疗后Cr(68.64±11.21)、BUN(15.13±1.44)、AI( 4.37±4.29)、NOS(11.57±2.25)和MDA(11.32±0.91)显著降低(P<0.05),SOD( 29.84±5.58)显著升高,差异有统计学意义(P<0.05)。结论 肾茶总黄酮能够减轻肾缺血再灌注损伤大鼠的急性肾损伤(AKI),这种作用可能通过下调肾小管上皮细胞的凋亡来实现,其机制可能是减少大鼠肾组织内自由基生成,增强其抗自由基损伤的能力。  相似文献   

8.
目的:探讨黄芩素对阿霉素肾病大鼠肾小管上皮细胞凋亡的调节作用。方法:18只雄性Wistar大鼠随机分为正常对照组(正常组,n=6)、阿霉素肾病组(模型组,n=6)和黄芩素治疗组(治疗组,n=6),模型组和治疗组一次性尾静脉注射阿霉素2.0mg/kg诱导阿霉素肾病动物模型,正常组注射等量生理盐水。造模后第1天开始,治疗组予黄芩素300 mg/(kg·d)灌胃,正常组和模型组予等量蒸馏水灌胃,共治疗8周。8周时留取各组大鼠24 h尿液标本及肾脏组织标本,使用TUNEL检测肾小管上皮细胞凋亡,免疫组化检测肾组织中caspase-3表达,western Blot方法检测肾皮质中Bcl-2及caspase-3蛋白水平。结果:与正常组比较,模型组24 h尿蛋白定量明显升高(P0.05),肾小管上皮细胞凋亡数量明显增加(P0.05),肾皮质中caspase-3蛋白水平明显增加(P0.05),Bcl-2蛋白水平明显下降(P0.05)。与模型组比较,治疗组24 h尿蛋白定量明显下降(P0.05),TUNEL阳性肾小管上皮细胞数量明显减少(P0.05),肾皮质中caspase-3蛋白水平明显下降(P0.05),Bcl-2蛋白水平明显增加(P0.05)。结论:黄芩素对阿霉素肾病具有一定的保护作用,其作用机制可能与调节肾小管上皮细胞凋亡有关。  相似文献   

9.
目的:观察HSP47在单侧输尿管梗阻(unilateral ureteral obstruction,UUO)大鼠模型肾脏组织的表达情况,探讨HSP47在肾小管间质纤维化中的作用。方法:将SD大鼠随机分为模型组(UUO组)和假手术组(Sham组),每组8只。采用单侧(左)输尿管结扎方法,建立梗阻性肾小管间质纤维化大鼠模型。术后第14天处死动物。观察两组间蛋白尿和血肌酐水平,运用HE和Masson染色观察肾脏组织形态学改变,采用免疫组织化学方法检测HSP47、胶原Ⅳ(CollagenⅣ)的表达。结果:与Sham组比较,UUO组大鼠血肌酐水平升高,蛋白尿差异无统计学意义。光镜下UUO组大鼠肾组织出现不同程度的肾小管扩张、间质炎症细胞浸润,间质面积增宽、部分肾小管萎缩、肾小管上皮细胞空泡样变性。Masson染色结果显示UUO组大鼠肾组织胶原在肾小管周围、间质区显著增多。免疫组织化学结果显示UUO组大鼠肾组织HSP47表达显著增加,在肾小管周围、间质区表达增加最明显;CollagenⅣ表达显著增加,在肾小管基底膜、间质区表达增加最明显。结论:HSP47在UUO大鼠模型肾脏组织中表达上调,且与胶原表达部位一致,提示HSP47促进肾间质纤维化,且该作用与其促进胶原蛋白的合成有关。  相似文献   

10.
目的:探讨肠黏膜上皮细胞的凋亡在大鼠腹部开放伤合并海水浸泡后肠屏障功能障碍中的作用。方法:观察腹腔海水浸泡后血浆二胺氧化酶(DAO)、内毒素(LPS)含量变化,肠组织丙二醛(MDA)、超氧化物歧化酶(SOD)含量,肠黏膜组织病理损伤程度;利用原位末端标记法计数肠黏膜上皮细胞凋亡指数。结果:腹部开放伤合并海水浸泡后,大鼠血浆DAO、LPS水平显著升高:肠组织MDA含量显著升高.SOD活性显著降低(P〈0.05或P〈0.01);小肠病理组织学检查显示肠黏膜屏障受损:小肠黏膜上皮细胞凋亡指数显著增加(P〈0.01)。结论:腹部开放伤合并海水浸泡可导致大鼠肠屏障功能障碍,出现肠源性内毒素血症,肠组织氧自由基损伤,肠黏膜上皮细胞凋亡明显增加,上皮细胞凋亡增加在肠屏障功能障碍发生中可能起重要作用。[著者文摘]  相似文献   

11.
OBJECTIVE: To observe the expression of peroxisome proliferation activated receptor gamma (PPARgamma) at different periods in renal interstitium and to study the effect of atorvastatin on the protein expression of PPARgamma in unilateral ureteral obstruction (UUO) in a rat model. METHODS: Forty-five female Sprague-Dawley (SD) rats were divided into three groups: the sham operation group, the model group and the atorvastatin group. The latter two groups underwent UUO and then received vehicle only or atorvastatin (10 mg.kg(-1).d(-1)) by daily gastric gavage, from three days before the UUO operation to the day of sacrifice . The sham operation rats received vehicle. Five rats of each group were sacrificed respectively at 5, 10 and 15 days after surgery. Histological changes in renal tissue were observed by hematoxylin and eosin (HE) and Masson stain. Immunohistochemistry for PPARgamma was performed in renal interstitium at each time point. RESULTS: Interstitial expansion and fibrosis in ureter obstructed kidney was prominent in the model group. Atorvastatin seemed to have ameliorated interstitial expansion and fibrosis in atorvastatin group. Detectable basic PPARgamma expression was observed in renal inner medulla of rats in sham operation group, and it was mainly concentrated in collecting tubules. In UUO rats, PPARgamma expression was found increased and extended to renal tubular epithelial cells. Increased PPARgamma expression was found on the 5th day after UUO, and significant PPARgamma expression was found on the 10 th day after UUO. The increased PPARgamma expression was found to be downregulated on the 15 th day after UUO, but still significantly increased compared with that of the model group at the same time point (all P<0.01). Atorvastatin could significantly increase the expression of PPARgamma as compared with the model group at each time point (all P<0.01). CONCLUSION: PPARgamma expression was found increased, and it appeared in renal tubular epithelial cells in UUO rats, Atorvastatin may play a protective role in the kidney by activating PPARgamma, thus alleviating renal interstitial fibrosis following UUO in rats.  相似文献   

12.
OBJECTIVE: To explore therapeutic effect of glutathione (GSH) on unilateral ureteral obstruction (UUO) induced renal interstitial fibrosis and its mechanism in rat. METHODS: Thirty-six adult healthy Wistar rats were randomly divided into 3 groups (each n=12): sham operation group, UUO group and GSH group. Rats in UUO group and GSH group underwent left unilateral ureteral ligation as described previously. Rats in sham group had their ureters manipulated but not ligated. In GSH group, GSH was injected intraperitoneally (100 mg.kg(-1).d(-1)) in different doses based on the animal's body weight, one day before UUO and then for consecutive 10 days after UUO. Meantime, same volume of physiological saline was given in sham operation and UUO groups as GSH group. Animals were sacrificed at 10 days after surgery. The pathological changes in obstructed kidney tissue were observed with hematoxylin and eosin (HE) and Masson stains. The contents of hydroxyproline (Hyp) and total antioxygen capability (T-AOC) were measured by chemical colorimetry method, the activity of total superoxide dismutase (T-SOD) was assayed by a modified xanthine/xanthine oxidase method, and the content of malondialdehyde (MDA) was determined by thiobarbituric acid method. RESULTS: Ten days after UUO, swelling and atrophy in renal parenchyma of obstructed kidneys were clearly observed. Fibrous material and monocyte infiltration were increased in the interstitial space. Furthermore, thickening of interstitial space of the tubular basement memberance and widening of the interstitial space of the renal cortex were noted. Hypertrophy or atrophy of juxtaglomerular tubules were also observed. There were cellular or albumin casts in a part of tubules. Interstitial fibrosis was observed in obstructed kidneys 10 days after UUO. The data indicated that ureteral obstruction significantly increased the contents of Hyp and MDA, but decreased the content of T-AOC and T-SOD activity, as compared with sham operation group [Hyp: (0.524+/-0.132) microg/mg, T-AOC: (1.48+/-0.21) U/mg, T-SOD: (12.77+/-0.76) U/mg, MDA: (2.65+/-0.32) nmol/mg, all P<0.01]. Compared with UUO group, pathological changes were milder and the contents of Hyp [(1.598+/- 0.252) microg/mg vs. (1.027+/-0.196) microg/mg, P<0.05] and MDA [(4.58+/-0.59) nmol/mg vs. (3.26+/- 0.34) nmol/mg, P<0.05] were significantly decreased in kidney of GSH group, meanwhile the content of T-AOC was increased [(0.67+/-0.19) U/mg vs. (0.94+/-0.17) U/mg, P<0.05], but the content of T-SOD did not show any change [(9.39+/-0.87) U/mg vs. (9.41+/-0.93) U/mg, P>0.05]. CONCLUSION: Reduced glutathione treatment attenuates UUO-induced renal interstitial fibrosis via decreasing content of Hyp in UUO kidney and preventing oxidation stress injury.  相似文献   

13.
背景:细胞黏附的丧失及E-钙黏蛋白表达下降在肾小管上皮细胞转分化导致肾间质纤维化疾病进展过程中发挥着的重要作用。目的:观察单侧输尿管梗阻模型大鼠肾小管间质纤维化动态及该病理过程中E-钙黏蛋白、整合素连接激酶蛋白的表达,探讨E-钙黏蛋白在肾小管间质纤维化中的作用机制。方法:72只SD大鼠随机摸球法均分为正常组、对照组和模型组。模型组建立单侧输尿管梗阻模型;对照组仅进行假手术;正常组不做任何处理。分别于造模后第1,3,7,14天分批处死大鼠,检测梗阻侧肾小管间质纤维化损伤程度并检测肾脏组织中E-钙黏蛋白、整合素连接激酶蛋白的表达。结果与结论:与正常组及对照组比较,模型组梗阻时间越长,肾小管间质损害程度越重,纤维化越明显。造模后3d大鼠肾脏组织E-钙黏蛋白mRNA及其蛋白表达水平即出现下调,第14天最低,整合素连接激酶蛋白表达则显著增加,与同期正常组、对照组相比,差异有显著性意义(P<0.05)。说明E-钙黏蛋白的表达减少促进了肾间质纤维化的发生、发展,而整合素连接激酶蛋白的表达增加在肾间质纤维化的进程中可能也发挥了重要作用。  相似文献   

14.
目的探讨丹参水提液对染镉大鼠肾损伤的干预作用及其可能的作用机制。方法健康Wistar大鼠,雌雄各20只,鼠龄6周。适应性喂养1周,随机分组,空白组8只,模型组32只,空白组腹腔注射生理盐水5 m L/(kg·d),模型组以2.8 mg/(kg·d)氯化镉溶液腹腔注射。连续造模4周,观察大鼠一般情况,检测大鼠肾功能指标、肾脏组织病理改变。造模成功后,将模型组随机分为给药组、阴性、阳性对照组及空白对照组。给药组[丹参水提液高剂量2.7 g/(kg·d)、丹参水提液低剂量1.35 g/(kg·d)]灌胃,阳性对照组亚硒酸钠溶液0.05 mg/(kg·d)灌胃,阴性及空白对照组给予同体积生理盐水2.7 m L/(kg·d)。各组治疗10周,实验终末收集血清、尿液,并留取肾脏组织,待检测。结果丹参水提液低、高剂量组24 h尿量低于阴性对照组,而血清超氧化物歧化酶(SOD)明显升高,丙二醛(MDA)显著降低,总抗氧化能力(T-AOC)增强明显,血尿素氮、血清肌酐含量降低,尿蛋白(β2-MG)含量下降。病理切片可见阴性对照组肾脏近曲小管上皮细胞浑浊、肿胀变性、坏死;丹参水提液低、高剂量组血清、皮质镉含量低于阴性对照组;丹参水提液低、高剂量组凋亡率低于阴性对照组。结论丹参水提液能加速体内镉代谢,可有效干预镉致肾损伤,有助于延缓慢性肾功能衰竭,改善肾功能,保护肾脏。  相似文献   

15.
目的研究真武汤对NF-κB蛋白表达的影响,从分子水平对真武汤治疗肾间质纤维化的机制进行探索。方法采用单侧输尿管结扎的方法(UUO)制备大鼠肾间质纤维化模型,将150只SPF级健康雄性wistar大鼠,随机分为假手术组、模型组、尿毒清组以及真武汤低、中、高剂量组。术后2周、3周、4周分别处死大鼠,收集尿液、血清,结扎单侧肾组织,对24 h尿蛋白、血肌酐、尿素氮含量进行检测,分别用免疫组织化学法、ELISA法检测NF-κB的表达。结果在各时间点,真武汤各给药组与模型组相比,大鼠梗阻侧肾脏肿大和积水程度较轻,血肌酐、尿素氮含量较低,肾组织和血清中NF-κB蛋白表达均较弱。结论真武汤可减少间质纤维化,减轻肾组织损伤,其延缓肾间质纤维化进程的作用机制可能是通过抑制NF-κB的表达来实现的。  相似文献   

16.
目的探讨螺内酯在老年慢性心力衰竭患者治疗中的作用。方法 62例老年慢性心力衰竭患者根据治疗方法不同分为常规组(30例)和螺内酯组(32例)。常规组:接受ACEI、洋地黄、噻嗪类利尿剂、β受体阻滞剂等常规治疗。螺内酯组:在常规治疗基础上口服螺内酯。观察各组患者在治疗前及治疗后4个月的血清BNP水平、LVEF、VE/VA,观察治疗后1个月的临床疗效。结果螺内酯组治疗后1个月的总有效率(90.6%)明显高于常规组(70%);螺内酯组治疗后LVEF、VE/VA较常规组明显升高(P〈0.05)。2组治疗后血清BNP水平均较治疗前明显降低,螺内酯组降低更加明显(P〈0.05)。结论螺内酯能明显改善老年慢性心力衰竭患者的心功能,降低血清BNP水平。  相似文献   

17.
A kinetic and hemodynamic study of digoxin was performed in six healthy subjects and similar studies were performed during digoxin with spironolactone and with triamterene. Spironolactone reduced renal tubular secretion of digoxin and attenuated its positive inotropic effect (evaluated by systolic time intervals and echocardiography) and triamterene reduced the extrarenal elimination of digoxin, but induced no changes in digoxin-elicited inotrophy. It is suggested that the renal handling of digoxin is influenced by the intracellular potassium concentration in the renal tubular cell. The results indicate a drug-receptor interaction between spironolactone metabolites and digoxin at the hypothetical inotropic digitalis receptor. Amiloride has been reported to suppress digoxin inotropism, whereas spironolactone induces minor inhibition and triamterene does not affect digoxin inotropism.  相似文献   

18.
目的探讨早期应用血必净对脓毒性急性肾损伤大鼠肾小管细胞凋亡,及相关蛋白B细胞淋巴瘤2(Bcl-2)和Bcl-2相关X蛋白(Bax)表达的影响。 方法54只雄性大鼠分为假手术组(Sham组)、脓毒症组(CLP组)、血必净组(CLP + XBJ组)三组,每组18只;以术后12、24和48 h作为时间观察点,将各组再分为3个亚组,每组6只。在各时间点检测大鼠的肌酐清除率(CrCl)、肾脏血流灌注量,并留取肾脏组织观察病理学变化,计算肾小管损伤评分,采用原位末端标记(TUNEL)法并通过计算积分光密度值(IOD)测定肾小管凋亡细胞,采用Western-blotting法测定肾脏髓质Bcl-2、Bax的变化。 结果三组大鼠的CrCl和肾脏血流灌注量在术后各时间点差异均有统计学意义(F = 6.405、18.821,P < 0.05);且CLP + XBJ组在术后48 h时CrCl和肾脏血流灌注量明显高于CLP组[(2.1 ± 0.5)ml/min/100 g vs.(1.1 ± 0.3)ml/min/100 g,(159 ± 38)BPU vs.(79 ± 32)BPU;P均< 0.05]。三组大鼠肾小管损伤评分比较,不同时间点差异存在统计学意义(F = 5.461,P < 0.05);且CLP + XBJ组与CLP组比较,24、48 h时评分均有显著下降[(1.6 ± 0.5)vs.(2.8 ± 0.8),(1.8 ± 0.8)vs.(3.6 ± 0.6);P均< 0.05]。三组大鼠各时间点凋亡细胞IOD值,差异存在统计学意义(F = 7.259,P < 0.05);CLP + XBJ组各时间点的IOD值均明显小于CLP组[(26.6 ± 6.9)vs.(34.4 ± 5.0),(38.2 ± 5.3)vs.(48.0 ± 5.8),(37.6 ± 2.2)vs.(53.8 ± 6.7);P均< 0.05]。同时,CLP + XBJ组能升高大鼠肾脏髓质Bcl-2的表达,抑制Bax的表达,维持Bcl-2/Bax的平衡,24、48 h时其Bcl-2[(1.30 ± 0.09)vs.(0.76 ± 0.09),(2.12 ± 0.38)vs.(0.51 ± 0.07);P均< 0.05]和Bax[(1.19 ± 0.37)vs.(1.95 ± 0.90),(1.48 ± 0.15)vs.(2.69 ± 0.39);P均< 0.05]的表达水平与脓毒症组相比差异均有统计学意义。 结论早期应用血必净可以减少肾小管细胞在脓毒症进程中的凋亡,改善脓毒性急性肾损伤大鼠肾脏的病理学改变,维持Bcl-2/Bax的平衡,减轻脓毒症导致的肾功能损害。  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号